ADVERTISEMENT RETURN TO ISSUEPREVEditorialNEXTIntroduction: Drug Discovery and Development for Neglected DiseasesLouise S. Goupil and James H. McKerrow*View Author Information University of California, San Francisco, University of California, San DiegoCite this: Chem. Rev. 2014, 114, 22, 11131–11137Publication Date (Web):November 26, 2014Publication History Published online26 November 2014Published inissue 26 November 2014https://pubs.acs.org/doi/10.1021/cr500546hhttps://doi.org/10.1021/cr500546heditorialACS PublicationsCopyright © 2014 American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views4504Altmetric-Citations42LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (1 MB) Get e-AlertscloseSUBJECTS:Drug discovery,Infectious diseases,Parasites,Pharmaceuticals,Targeting Get e-Alerts
No takes yet. Share an insight, caveat, or question.
Goupil et al. (2014) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: